Summary of Significant Accounting Policies - Revenue Recognition (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($) item	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) agreement item	Jun. 30, 2022 USD ($)
Disaggregation of Product Revenue
Number of contracts | agreement			2
Mytesi
Disaggregation of Product Revenue
Product revenue	$ 2,600,000	$ 2,800,000	$ 4,600,000	$ 5,400,000
Number of specialty pharmacies. | item	5		5
Mytesi | Specialty Pharmacies
Disaggregation of Product Revenue
Product revenue	$ 1,500,000	2,400,000	$ 3,500,000	4,700,000
Canalevia-CA1
Disaggregation of Product Revenue
Product revenue	39,000	87,000	67,000	131,000
Neonorm
Disaggregation of Product Revenue
Product revenue	$ 18,000	$ 15,000	$ 28,000	$ 35,000